Figure 2
Figure 2. Event-free-survival in 252 patients according to cytogenetic subgroup. The 6 patients not receiving AML chemotherapy were excluded from this analysis.

Event-free-survival in 252 patients according to cytogenetic subgroup. The 6 patients not receiving AML chemotherapy were excluded from this analysis.

Close Modal

or Create an Account

Close Modal
Close Modal